George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,800 shares at $620.00 ($2.3M) on 2021-08-11, disclosed to the SEC on 2021-08-13.
Open-market sale of $2.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $620.00 | 300 | $186K | 7.9% |
| 2 | $620.00 | 1,000 | $620K | 26.4% |
| 3 | $621.00 | 1,000 | $621K | 26.4% |
| 4 | $611.00 | 1,000 | $611K | 26.0% |
| 5 | $620.00 | 500 | $310K | 13.2% |
| Total | $617.89 avg | 3,800 |
| $2.3M |
| 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |